Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA CEO Search On Hold; Tauzin Will Wait On Decision

Executive Summary

Rep. Billy Tauzin (R-La.) has suspended discussions with the Pharmaceutical Research & Manufacturers of America to become the trade association's CEO, his office said Feb. 26

You may also be interested in...



PhRMA CEO Selection Day Nears Now That Election Day Has Passed

The Pharmaceutical Research & Manufacturers of America is expected to finalize the succession plan for CEO Alan Holmer during its annual strategy session Nov. 11 and 12

PhRMA On The “Defensive”: Sen. Breaux Notes Criticism Is Bipartisan

The brand name pharmaceutical industry must recognize that it is a convenient political target for members of Congress in both parties, Sen. John Breaux (D-La.) warned the Pharmaceutical Research & Manufacturers of America during the association's annual meeting April 3 in Palm Beach, Fla

PhRMA On The “Defensive”: Sen. Breaux Notes Criticism Is Bipartisan

The brand name pharmaceutical industry must recognize that it is a convenient political target for members of Congress in both parties, Sen. John Breaux (D-La.) warned the Pharmaceutical Research & Manufacturers of America during the association's annual meeting April 3 in Palm Beach, Fla

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel